Correction to: Oncogene (2017) 36, 1537–1545; doi:10.1038/onc.2016.320; published online 3 October 2016
Following the publication of this article the authors note that they inadvertently omitted the correct acknowledgement for the support from the NIH and The Carl and Roberta Deutsch Foundation for the above referenced paper.
The corrected acknowledgement should read:
We acknowledge The Carl and Roberta Deutsch Foundation (PI: Farias-Eisner), Kelly Day, and NIH/NCI U54CA143930 Grant (PI: Farias-Eisner) for their financial support. We thank Professor Oliver Dorigo, Stanford University Medical Center, for the generous gift of cisplatin-resistant ovarian cancer cell lines. We thank Dr Xiangming Ding, UCLA Clinical Microarray Core, for the statistical assistance.
The authors apologise for any inconvenience caused by this error.
Additional information
The online version of the original article can be found at 10.1038/onc.2016.320
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Ramadoss, S., Sen, S., Ramachandran, I. et al. Erratum: Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance. Oncogene 36, 6508 (2017). https://doi.org/10.1038/onc.2017.331
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2017.331
